Get in touch

Carteret Health Care Medical Group

302 Medical Park Court
Morehead City, NC 28577
Phone: (252) 247-2013

Carteret Medical Group - Cedar Point

1165 Cedar Point Blvd, Ste. H
Cedar Point, NC 28584
Visit us online

Mary Katherine Lawrence MD

Endocrinology & Metabolism


Dr. Mary Katherine Lawrence has practiced in Morehead City since 1994.  Her areas of focus are diabetes, thyroid disease, and the detection, prevention and treatment of osteoporosis.

In addition to providing care for her patients at Carteret Medical Group, Dr. Lawrence serves as medical director of the Broad Street Clinic, a free health clinic serving adult residents of Carteret County and surrounding area.   With a grant from the Carteret Health Care Foundation, Dr. Lawrence launched a BoneFit™ exercise and education program for individuals with osteoporosis, osteopenia and those at risk for bone fractures.  In her free time, she is a devotee of CrossFit, biking, and travel. 

Endocrinology & Metabolism
Internal Medicine-American Board of Internal Medicine

UNC-Chapel Hill

George Washington University School of Medicine

Vanderbilt University Hospitals

Diabetes and Thyroid Disease
Osteoporosis detection, prevention and treatment

American College of Endocrinologists-Fellow;
Certified-International Society of Bone Densitometry;
Medical Director, Broad Street Clinic;
Chief of Staff-Carteret General Hospital-2011,
Former Credentials Committee Chair;
Member-Physicians for Social Responsibility.

As a principal investigator, Dr. Lawrence conducts clinical studies in promising new treatments for diabetes and associated conditions. Patients who participate in a clinical study can learn more about their disease and its treatment, contribute to medical knowledge, and take advantage of study-related visits and procedures at no cost.  

Below is a list of some of the approved medications for which Dr. Lawrence has conducted studies.

Afrezza® rapid-acting inhaled insulin

Symlin® (pramlintide) for diabetic patients taking insulin

Glyset® (miglitol) to control blood glucose levels in Type 2 diabetes

Amaryl® (glimepiride) sulfonylurea for Type 2 diabetes

Pravachol® (pravastatin) to lower cholesterol

Januvia® (sitagliptin) for Type 2 diabetes

Bydureon ER® (exenatide) weekly injection for Type 2 diabetes

Farxiga® (dapagliflozin) for glycemic control in Type 2 diabetes

Ozempic® (semaglutide) weekly injection in Type 2 diabetes

Xolair® (omalizumab) for moderate to severe asthma

AndroGel® testosterone replacement therapy

PRINCIPAL INVESTIGATOR in all of the following:
Inhaled Insulin in Type 1 Diabetics
Renal Failure in Type 2 Diabetics
Cantata-02, SGLT 2 Inhibitor
GBBD, type 2 diabetes on insulin
Target Diabetic neuropathy, aldose reductase
Renal Insufficiency in Diabetes
Milly, Asthma
Drug Naive Type 2 Diabetes, SGLT inhibitor
Toccato: Rimonabontin Diabetes
E2008 Diabetic Neuropathy
E2007 Diabetic Neuropathy
Extra Xolair in Asthma
DPP-4 in Drug Naive Diabetes
CV-168 Drug Naive Type 2 Diabetes
Ascend Diabetic Nephropathy
Symlin in Type 1 and 2 Diabetes
IDAS-Inhaled Insulin in Asthma/COPD
IDAH-Inhaled Insulin in Type I DM
IDAP-Inhaled Insulin in Type II DM
DPP-4 Inhibitor in Diabetic Nephropathy
TREAT Anemia in Diabetic Nephropathy
Matrix Urinary Incontinence
Domperodine Trial Diabetic Gastroparesis
Trumpet-Hyperlipidemia
Smart Study-Asthma
Glimepiridein Type 2 Diabetes
Miglitol in Type 2 Diabetes
SUB-INVESTIGATOR
Bisphosphomates in Osteoporosis
Testostrone Replacement in Type 2 Diabetes
Pravastatin in Hyperlipidemia